SHELLY RONAYNE: Open Payments
NPI 1023388220 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 45 payments from 8 companies in 2025. Trend: 2023 $1,341 · 2024 $1,688 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 10 | $234 |
| Lilly USA, LLC | 13 | $191 |
| Novo Nordisk Inc | 10 | $165 |
| Dexcom, Inc. | 4 | $89 |
| GENZYME CORPORATION | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: FREESTYLE LIBRE, Ozempic, MOUNJARO, Dexcom G6 Transmitter, KISUNLA, FABRAZYME, INSPIRE, AREXVY.
Industry payments across MO — which companies pay providers there.
